Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity
Science · 15.01.2026 · 391 (6782)
DOI: 10.1126/science.adq9006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 15.01.2026. Verfasst von Danhui Liu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Obesity, Inflammasomes, SAM Domain and HD Domain-Containing Protein 1. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Obesity is a major disease risk factor due to obesity-associated hyperinflammation. We found that obesity induced Nod-like receptor pyrin domain–containing 3 (NLRP3) inflammasome hyperactivation and excessive interleukin (IL)–1β production in macrophages by disrupting SAM and HD domain–containing protein 1 (SAMHD1), a deoxynucleoside triphosphate (dNTP) hydrolase crucial for nucleotide balance. This caused aberrant accumulation of dNTPs, which can be transported into mitochondria, and initiated mitochondrial DNA (mtDNA) neosynthesis, which increased the presence of oxidized mtDNA and triggered NLRP3 hyperactivation. Deletion of SAMHD1 promoted NLRP3 hyperactivation in cells isolated from zebrafish, mice, and humans. SAMHD1-deficient mice showed elevated circulating IL-1β, insulin resistance, and metabolic dysfunction–associated steatohepatitis. Blocking dNTP mitochondrial transport prevented NLRP3 hyperactivation in macrophages from obese patients and SAMHD1-deficient mice. Our study revealed that obesity by inhibiting SAMHD1 rewired macrophage nucleotide metabolism, thereby triggering NLRP3 inflammasome hyperactivation to drive disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Medical Research Council Translational Immune Discovery Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
- Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
ORCID-Profile: Danhui Liu, Chuanli Zhou, Xiaochen Wang, Zhou Luo, Xuemei Luo, Shuhan Yang, Arielle Click, Hamid Baniasadi, Nan Yan, Jan Rehwinkel, Dustin C Hancks, Shuang Liang, Zhenyu Zhong
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Liu, D., Zhou, C., Wang, X., Luo, Z., Xu, R., Huo, S., Guo, L., Luo, X., Yang, S., Click, A., Vancil, J., Barajas, P., Mijares, V., Baniasadi, H., Yan, N., Rehwinkel, J., Hancks, D. C., Chen, E. H., Liang, S., & Zhong, Z. (2026). Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity. Science, 391(6782). https://doi.org/10.1126/science.adq9006
Vancouver
Liu D, Zhou C, Wang X, Luo Z, Xu R, Huo S, et al. Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity. Science. 2026;391(6782). doi:10.1126/science.adq9006
BibTeX
@article{Liu2026,
author = {Liu, Danhui and Zhou, Chuanli and Wang, Xiaochen and Luo, Zhou and Xu, Ruiyao and Huo, Shanshan and Guo, Lina and Luo, Xuemei and Yang, Shuhan and Click, Arielle and Vancil, Janiece and Barajas, Paola and Mijares, Victor and Baniasadi, Hamid and Yan, Nan and Rehwinkel, Jan and Hancks, Dustin C and Chen, Elizabeth H and Liang, Shuang and Zhong, Zhenyu},
title = {Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity},
journal = {Science},
year = {2026},
volume = {391},
number = {6782},
doi = {10.1126/science.adq9006}
}
EUVIMED